Safety and Efficacy Study of Enzalutamide Versus Bicalutamide in Men With Prostate Cancer

NCT01664923 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

396

Enrollment

INDUSTRY

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: Enzalutamide
DRUG: Bicalutamide

Sponsor

Pfizer

Collaborators

[object Object]
[object Object]